access pathways to large international markets that do not classify hemp as a controlled substance and encourage drug development exemptions within the pharma industry and clinical sciences.
MSC will differentiate our laboratory services and strengthen consultation agreements into channels that will regard Canadian Cannabis and Hemp as being the safest and most carefully controlled for public health across the globe. Investment in research, development and analysis will also allow for the ability to produce careful, accurate and effective dosage from these research programs.
Moreover, we are excited to assist in the training of students and post-doctoral fellowships across Canada with assets that have never been deployed in other Laboratory businesses before. Our aim is to help these individuals develop and provide great expertise in handling these materials and emerge as skilled operators for highly sensitive and sophisticated mass spectrometers.
193